Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for ...

Portfolio Receipts growth of 15% to $735 million; Royalty Receipts growth of 15%Net cash provided by operating activities of $704 millionCapital ...

The headline numbers for Royalty Pharma (RPRX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall ...

Marshall Urist; Executive Vice President - Research and Investments; Royalty Pharma PLC Christopher Hite; Vice Chairman, Executive Vice President; Royalty Pharma PLC Terrance Coyne; Chief Financial ...

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

Guggenheim raised the firm’s price target on Johnson & Johnson to $162 from $156 and keeps a Neutral rating on the shares. The firm ...

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

Archaeologists working at Tel Shimron in northern Israel have uncovered an enormous ancient structure filled with Canaanite cultic artifacts. This remarkable collection includes objects likely used in ...

Israel State Auditor Holds Tax Authority Accountable for $800M Crypto Tax Gap: Report ...